Eyenovia Inc (NASDAQ: EYEN) Becomes The New Buzzing Stock: Sports A Monthly Volatility Of 9.42%

Eyenovia Inc (NASDAQ:EYEN) does about 1.68M shares in volume on a normal day but saw 603031 shares change hands in the recent trading day. The company now has a market cap of 46.44M USD. Its current market price is $0.54, marking a decrease of -2.18% compared to the previous close of $0.56. The 52 week high reached by this stock is $2.57 whilst the lowest price level in 52 weeks is $0.37.

Eyenovia Inc (EYEN) has a 20-day trading average at $0.4889 and the current price is -78.88% off the 52-week high compared with 46.73% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.5413 and its 200-day simple moving average is $1.0058. If we look at the stock’s price movements over the week, volatility stands at 14.34%, which decreases to 9.42% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 53.71 to suggest the stock is neutral.

The consensus objective for the share price is $7.67, suggesting that the stock has a potential upside of 92.96% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 01, 2021 when Northland Capital initiated the stock to “Outperform” and issued a price target of $10.

The current price level is 11.10%, 0.31%, and -46.02% away from its SMA20, SMA50, and SMA200 respectively, with the EYEN price moving above the 50-day SMA on current market day. Eyenovia Inc (EYEN) stock is up 20.59% over the week and 18.59% over the past month. Its price is -73.90% year-to-date and -58.24% over the past year.

To reach the target analysts have set, the stock logically needs to grow 92.96 percent from here.

Outstanding shares total 85.54M with insiders holding 10.00% of the shares and institutional holders owning 13.60% of the company’s common stock. The company has a return on investment of -1184.92% and return on equity of -914.66%. The beta has a value of 1.75. Price to sales ratio is 1547.99.